-
1
-
-
78651348100
-
Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2
-
Hummel CS, Lu C, Loo DD, Hirayama BA, Voss AA, Wright EM. Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2. Am J Physiol Cell Physiol 2011;300:C14-C21
-
(2011)
Am J Physiol Cell Physiol
, vol.300
-
-
Hummel, C.S.1
Lu, C.2
Loo, D.D.3
Hirayama, B.A.4
Voss, A.A.5
Wright, E.M.6
-
2
-
-
0027948971
-
Molecular physiology of sodium-glucose cotransporters
-
Hediger MA, Rhoads DB. Molecular physiology of sodium-glucose cotransporters. Physiol Rev 1994;74:993-1026 (Pubitemid 24328943)
-
(1994)
Physiological Reviews
, vol.74
, Issue.4
, pp. 993-1026
-
-
Hediger, M.A.1
Rhoads, D.B.2
-
3
-
-
40849145722
-
+/glucose cotransporters
-
DOI 10.1124/jpet.107.129825
-
Pajor AM, Randolph KM, Kerner SA, Smith CD. Inhibitor binding in the human renal low- and high-affinity Na+/glucose cotransporters. J Pharmacol Exp Ther 2008;324:985-991 (Pubitemid 351397847)
-
(2008)
Journal of Pharmacology and Experimental Therapeutics
, vol.324
, Issue.3
, pp. 985-991
-
-
Pajor, A.M.1
Randolph, K.M.2
Kerner, S.A.3
Smith, C.D.4
-
4
-
-
64749094872
-
Effect of diabetes and insulin of the maximum capacity of the renal tubules to reabsorb glucose
-
Farber SJ, Berger EY, Earle DP. Effect of diabetes and insulin of the maximum capacity of the renal tubules to reabsorb glucose. J Clin Invest 1951;30:125-129
-
(1951)
J Clin Invest
, vol.30
, pp. 125-129
-
-
Farber, S.J.1
Berger, E.Y.2
Earle, D.P.3
-
5
-
-
0015122757
-
Maximum tubular reabsorption capacity for glucose and renal hemodynamics during rapid hypertonic glucose infusion in normal and diabetic subjects
-
Mogensen CE. Maximum tubular reabsorption capacity for glucose and renal hemodynamics during rapid hypertonic glucose infusion in normal and diabetic subjects. Scand J Clin Lab Invest 1971;28:101-109
-
(1971)
Scand J Clin Lab Invest
, vol.28
, pp. 101-109
-
-
Mogensen, C.E.1
-
6
-
-
33644688031
-
Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes
-
DOI 10.2337/diabetes.54.12.3427
-
Rahmoune H, Thompson PW, Ward JM, Smith CD, Hong G, Brown J. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes 2005;54:3427-3434 (Pubitemid 43334332)
-
(2005)
Diabetes
, vol.54
, Issue.12
, pp. 3427-3434
-
-
Rahmoune, H.1
Thompson, P.W.2
Ward, J.M.3
Smith, C.D.4
Hong, G.5
Brown, J.6
-
7
-
-
10744229025
-
Molecular Analysis of the SGLT2 Gene in Patients with Renal Glucosuria
-
DOI 10.1097/01.ASN.0000092790.89332.D2
-
Santer R, Kinner M, Lassen CL, et al. Molecular analysis of the SGLT2 gene in patients with renal glucosuria. J Am Soc Nephrol 2003;14:2873-2882 (Pubitemid 37305650)
-
(2003)
Journal of the American Society of Nephrology
, vol.14
, Issue.11
, pp. 2873-2882
-
-
Santer, R.1
Kinner, M.2
Lassen, C.L.3
Schneppenheim, R.4
Eggert, P.5
Bald, M.6
Brodehl, J.7
Daschner, M.8
Ehrich, J.H.H.9
Kemper, M.10
Li, V.S.11
Neuhaus, T.12
Skovby, F.13
Swift, P.G.F.14
Schaub, J.15
Klaerke, D.16
-
8
-
-
0023275573
-
Correction of hyperglycemia with phlorizin normalizes tissues sensitivity to insulin in diabetic rats
-
Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 1987;79:1510-1515 (Pubitemid 17099657)
-
(1987)
Journal of Clinical Investigation
, vol.79
, Issue.5
, pp. 1510-1515
-
-
Rossetti, L.1
Smith, D.2
Shulman, G.I.3
-
9
-
-
79952404360
-
SGLT2 deletion improves glucose homeostasis and preserves pancreatic β-cell function
-
Jurczak MJ, Lee H-Y, Birkenfeld AL, et al. SGLT2 deletion improves glucose homeostasis and preserves pancreatic β-cell function. Diabetes 2011;60:890-898
-
(2011)
Diabetes
, vol.60
, pp. 890-898
-
-
Jurczak, M.J.1
Lee, H.-Y.2
Birkenfeld, A.L.3
-
10
-
-
67349180574
-
Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects
-
Komoroski B, Vachharajani N, Boulton D, et al. Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects. Clin Pharmacol Ther 2009;85:520-526
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 520-526
-
-
Komoroski, B.1
Vachharajani, N.2
Boulton, D.3
-
11
-
-
67349275999
-
Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus
-
Komoroski B, Vachharajani N, Feng Y, Li L, Kornhauser D, Pfister M. Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus. Clin Pharmacol Ther 2009;85:513-519
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 513-519
-
-
Komoroski, B.1
Vachharajani, N.2
Feng, Y.3
Li, L.4
Kornhauser, D.5
Pfister, M.6
-
12
-
-
69549095914
-
A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: Applicability of a novel insulin-independent treatment
-
Wilding JP, Norwood P, T'joen C, Bastien A, List JF, Fiedorek FT. A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment. Diabetes Care 2009;32:1656-1662
-
(2009)
Diabetes Care
, vol.32
, pp. 1656-1662
-
-
Wilding, J.P.1
Norwood, P.2
T'joen, C.3
Bastien, A.4
List, J.F.5
Fiedorek, F.T.6
-
13
-
-
77956921439
-
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
-
Ferrannini E, Ramos SJ, Salsali A, Tang W, List JF. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes Care 2010;33:2217-2224
-
(2010)
Diabetes Care
, vol.33
, pp. 2217-2224
-
-
Ferrannini, E.1
Ramos, S.J.2
Salsali, A.3
Tang, W.4
List, J.F.5
-
14
-
-
77953857048
-
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: A randomised, double-blind, placebo-controlled trial
-
Bailey CJ, Gross JL, Pieters A, Bastien A, List JF. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet 2010;375:2223-2233
-
(2010)
Lancet
, vol.375
, pp. 2223-2233
-
-
Bailey, C.J.1
Gross, J.L.2
Pieters, A.3
Bastien, A.4
List, J.F.5
-
15
-
-
78651406659
-
SGLT2 mediates glucose reabsorption in the early proximal tubule
-
Vallon V, Platt KA, Cunard R, et al. SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol 2011;22:104-112
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 104-112
-
-
Vallon, V.1
Platt, K.A.2
Cunard, R.3
-
16
-
-
41649087328
-
Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
-
DOI 10.1021/jm701272q
-
Meng W, Ellsworth BA, Nirschl AA, et al. Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. J Med Chem 2008;51:1145-1149 (Pubitemid 351480378)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.5
, pp. 1145-1149
-
-
Meng, W.1
Ellsworth, B.A.2
Nirschl, A.A.3
McCann, P.J.4
Patel, M.5
Girotra, R.N.6
Wu, G.7
Sher, P.M.8
Morrison, E.P.9
Biller, S.A.10
Zahler, R.11
Deshpande, P.P.12
Pullockaran, A.13
Hagan, D.L.14
Morgan, N.15
Taylor, J.R.16
Obermeier, M.T.17
Humphreys, W.G.18
Khanna, A.19
Discenza, L.20
Robertson, J.G.21
Wang, A.22
Han, S.23
Wetterau, J.R.24
Janovitz, E.B.25
Flint, O.P.26
Whaley, J.M.27
Washburn, W.N.28
more..
-
17
-
-
77950524984
-
Neuronal regulation of homeostasis by nutrient sensing
-
Lam TK. Neuronal regulation of homeostasis by nutrient sensing. Nat Med 2010;16:392-395
-
(2010)
Nat Med
, vol.16
, pp. 392-395
-
-
Lam, T.K.1
|